HPC
LH icon

HM Payson & Co’s Labcorp LH Stock Holding History

HM Payson & Co’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Sell
2,039
-175
-8% -$46K 0.01% 288
2026
Q1 		$591K Hold
2,214
– – 0.01% 276
2025
Q4 		$555K Hold
2,214
– – 0.01% 281
2025
Q3 		$636K Sell
2,214
-126
-5% -$33.8K 0.01% 262
2025
Q2 		$614K Hold
2,340
– – 0.01% 261
2025
Q1 		$545K Hold
2,340
– – 0.01% 274
2024
Q4 		$537K Sell
2,340
-550
-19% -$126K 0.01% 271
2024
Q3 		$646K Sell
2,890
-966
-25% -$212K 0.01% 260
2024
Q2 		$785K Sell
3,856
-47
-1% -$9.56K 0.01% 226
2024
Q1 		$853K Sell
3,903
-10,164
-72% -$2.24M 0.02% 223
2023
Q4 		$3.2M Sell
14,067
-80,178
-85% -$16.8M 0.07% 128
2023
Q3 		$18.9M Sell
94,245
-63,490
-40% -$13.4M 0.44% 54
2023
Q2 		$32.7M Buy
157,735
+1,264
+0.8% +$245K 0.73% 43
2023
Q1 		$30.8M Sell
156,471
-17,471
-10% -$3.6M 0.74% 45
2022
Q4 		$35.2M Buy
173,942
+106,544
+158% +$20.8M 0.88% 40
2022
Q3 		$11.9M Buy
67,398
+9,176
+16% +$1.88M 0.33% 62
2022
Q2 		$11.7M Sell
58,222
-29,826
-34% -$6.36M 0.3% 68
2022
Q1 		$19.9M Buy
88,048
+735
+0.8% +$173K 0.45% 57
2021
Q4 		$23.6M Buy
87,313
+9,674
+12% +$2.39M 0.51% 54
2021
Q3 		$18.8M Buy
77,639
+24,124
+45% +$6.08M 0.46% 56
2021
Q2 		$12.7M Buy
53,515
+50,584
+1,726% +$11.5M 0.31% 70
2021
Q1 		$642K Buy
2,931
+128
+5% +$25.7K 0.02% 248
2020
Q4 		$490K Buy
2,803
+64
+2% +$11.1K 0.01% 272
2020
Q3 		$443K Sell
2,739
-23
-0.8% -$3.65K 0.01% 262
2020
Q2 		$394K Hold
2,762
– – 0.01% 257
2020
Q1 		$300K Sell
2,762
-76
-3% -$10.9K 0.01% 264
2019
Q4 		$412K Hold
2,838
– – 0.01% 280
2019
Q3 		$410K Buy
2,838
+61
+2% +$8.9K 0.01% 282
2019
Q2 		$413K Buy
+2,777
New +$387K 0.01% 287
2018
Q4 		– Sell
-3,243
Closed -$484K – 250
2018
Q3 		$484K Hold
3,243
– – 0.02% 232
2018
Q2 		$500K Hold
3,243
– – 0.02% 227
2018
Q1 		$451K Hold
3,243
– – 0.02% 234
2017
Q4 		$444K Hold
3,243
– – 0.02% 249
2017
Q3 		$421K Hold
3,243
– – 0.02% 242
2017
Q2 		$429K Sell
3,243
-175
-5% -$21.4K 0.02% 243
2017
Q1 		$421K Hold
3,418
– – 0.02% 240
2016
Q4 		$377K Sell
3,418
-116
-3% -$12.9K 0.02% 243
2016
Q3 		$417K Sell
3,534
-337
-9% -$39.7K 0.02% 229
2016
Q2 		$433K Sell
3,871
-437
-10% -$47K 0.02% 224
2016
Q1 		$433K Sell
4,308
-1,017
-19% -$97.5K 0.02% 216
2015
Q4 		$566K Sell
5,325
-184
-3% -$19K 0.03% 207
2015
Q3 		$514K Sell
5,509
-169
-3% -$17.5K 0.03% 207
2015
Q2 		$591K Sell
5,678
-221
-4% -$23K 0.03% 204
2015
Q1 		$639K Sell
5,899
-181
-3% -$18.6K 0.03% 202
2014
Q4 		$563K Sell
6,080
-1,222
-17% -$108K 0.03% 217
2014
Q3 		$638K Sell
7,302
-1,420
-16% -$128K 0.03% 203
2014
Q2 		$767K Sell
8,722
-2,345
-21% -$203K 0.04% 188
2014
Q1 		$934K Sell
11,067
-36,056
-77% -$2.88M 0.05% 166
2013
Q4 		$3.7M Sell
47,123
-3,155
-6% -$269K 0.2% 101
2013
Q3 		$4.28M Sell
50,278
-1,944
-4% -$164K 0.25% 90
2013
Q2 		$4.49M Buy
+52,222
New +$4.34M 0.27% 86

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
WIC
WealthBridge Investment Counsel Calgary, Alberta, Canada $375M AUM 37.9% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

HM Payson & Co's LH Position: Q2 2026 in Review

HM Payson & Co reduced its Labcorp (LH) stake by 7.9% in Q2 2026, selling an estimated $46K and leaving 2,039 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #288.

HM Payson & Co first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $35.2M in Q4 2022. 145 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • HM Payson & Co held 2,039 shares of Labcorp worth $571K as of Q2 2026.
  • HM Payson & Co sold 175 Labcorp shares in Q2 2026, an estimated $46K.
  • Labcorp made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #288 holding.
  • HM Payson & Co first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • HM Payson & Co's Labcorp position peaked at $35.2M in Q4 2022.
  • 145 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.